Table 1 Clinical characteristics of study participants
From: Assessment of Parkinsonian gait in older adults with dementia via human pose tracking in video data
|  | Study Participants (n = 14) Mean ± SD | |
Age | 76.2 ± 8.7 | |
Sex (% male) | 57.1 | |
Number of Walks | 28.6 ± 11.8 | |
Total Severe Impairment Battery (SIB) Score | 27.9 ± 13.1 | |
Total Neuropsychiatric Inventory (NPI) Score | 46.3 ± 19.5 | |
Total Katz Index of Independence in Activities of Daily Living Score | 2.3 ± 1.3 | |
Total Tinetti POMA Balance Score | 9.9 ± 3.1 | |
Total Tinetti POMA Gait Score | 8.4 ± 2.8 | |
Antipsychotic Medication Use | Study Participants Prescribed Medication (n = 14) | Daily Dose (mg) Mean ± SD |
Risperidone | 3 (21.4%) | 0.5 ± 0.4 |
Quetiapine | 11 (78.6%) | 64.2 ± 61.8 |
Clozapine | 2 (14.3%) | 32.4 ± 7.2 |
Loxapine | 5 (35.7%) | 5.5 ± 1.1 |
Olanzapine | 2 (14.3%) | 1.9 ± 0.9 |
Nozinan | 2 (14.3%) | 12.8 ± 3.8 |